Hollow-fibre membrane with improved biocompatibility and reduced elution of hydrophilic polymers

Patent metadata

Field	Value
Publication number	US-11484844-B2
Application number	US-201816481492-A
Country	US
Kind code	B2
Filing date	Jan 31, 2018
Priority date	Feb 1, 2017
Publication date	Nov 1, 2022
Grant date	Nov 1, 2022

Abstract

The invention relates to the providing of hydrophobic and hydrophilic polymer-based hollow fiber membranes containing a water-insoluble antioxidant; in particular, the invention relates to the providing of hollow fiber membranes for the extracorporeal treatment of blood, wherein the hollow fiber membranes have improved biocompatibility relative to treatment blood, in particular improved complement activation and lower platelet loss vis-à-vis treatment blood. At the same time, the elution of hydrophilic polymers from the lumen of the hollow fiber membrane is reduced.

First claim

The invention claimed is:

1. A method for manufacturing a hollow fiber membrane comprising the method steps:
preparing at least one spin mass comprising a hydrophobic polymer comprising a polysulfone and a hydrophilic polymer comprising a polyvinylpyrrolidone, at least one aprotic polar solvent and one water-insoluble antioxidant,
preparing at least one coagulant comprising at least one aprotic polar solvent and/or at least one non-solvent,
conveying the spin mass through at least one annular gap of a spinneret into a hollow strand,
conveying the coagulant through a central bore of the spinneret into the lumen of the strand,
introducing the strand into a precipitating bath,

wherein the spin mass contains 0.001 to 0.05% by weight of the water-insoluble antioxidant and the coagulant furthermore comprises at least one hydrophilic polymer that includes a polyvinylpyrrolidone, and wherein the coagulant contains 0.5 g to 4 g of said polyvinylpyrrolidone in said coagulant per kg of said coagulant, the spin mass contains from 2% to 7% by weight polyvinylpyrrolidone relative to total mass of the spin mass, the weight average molecular weight (Mw) of the polyvinylpyrrolidone in the spin mass is from 500,000 g/mol to less than 1,000,000 g/mol, and the weight average molecular weight (Mw) of the polyvinylpyrrolidone in the coagulant is from 1,000,000 g/mol to 3,000,000 g/mol.

2. A hollow fiber membrane having a membrane material comprising a hydrophobic polymer comprising a polysulfone and a hydrophilic polymer as well as at least one water-insoluble antioxidant wherein the water-insoluble antioxidant is present at 0.005 to 0.25% by weight ratio in relation to the total weight of the hollow fiber membrane, wherein the hydrophilic polymer comprises polyvinylpyrrolidone, and wherein the hollow fiber membrane has a near-surface layer and a polyvinylpyrrolidone content in the near-surface layer of an inner lumen of the hollow fiber membrane amounts to 26% to 34% by weight pursuant to an XPS measurement method, and wherein the hollow fiber membrane has said polyvinylpyrrolidone content of from 3% to 5% (w/w).

3. The hollow fiber membrane according to claim 2 wherein the elution of the hydrophilic polymer amounts to less than 4000*10 −7 mg per individual fiber after being stored for a period of 30 days at 80° C. and <5% relative humidity.

4. The hollow fiber membrane according to claim 2 , wherein additional polyvinylpyrrolidone is applied to at least one surface of the hollow fiber membrane.

5. The hollow fiber membrane according to claim 2 , wherein the hollow fiber membrane has a lumen-side and the hollow fiber membrane has a zeta potential on the lumen-side surface of −1 mV to less than −7 mV.

6. The hollow fiber membrane according to claim 2 , wherein the hollow fiber membrane has a surface layer and a peak height ratio of CNO − and SO 2 − amounts to 4.5 or higher on the surface layer of an inner lumen of the hollow fiber membrane as determined by TOF-SIMS.

7. The hollow fiber membrane according to claim 2 , wherein the weight average molecular weight (Mw) of the polyvinylpyrrolidone present on a surface of a lumen of the hollow fiber membrane is higher than the weight average molecular weight of the polyvinylpyrrolidone elsewhere in the membrane.

8. The hollow fiber membrane according to claim 7 , wherein the weight average molecular weight (Mw) of the polyvinylpyrrolidone at the surface of the lumen is greater than 1,000,000 g/mol and the weight average molecular weight (Mw) of the polyvinylpyrrolidone elsewhere in the membrane is less than 1,000,000 g/mol.

9. The method according to claim 1 , wherein a ratio of the weight-average molecular weights of the polyvinylpyrrolidone in the coagulant to the weight-average molecular weight of the polyvinylpyrrolidone in the spin mass is at least 1.2.

10. The hollow fiber membrane according to claim 2 , wherein the ratio of the sieving coefficients for albumin measured after 5 min to the sieving coefficient measured after 30 min according to the measurement method of the description is less than 7.

11. The hollow fiber membrane according to claim 2 , wherein the ratio of the sieving coefficients for albumin, measured after 5 min, to the sieving coefficient, measured after 10 min, according to the measurement method of the description, is less than 3.

12. The hollow fiber membrane according to claim 2 , wherein the hollow fiber membrane has an inner lumen and a surface of the inner lumen has a contact angle with water, measured according to the method “Determination of the contact angle θ”, of less than 57.

13. The hollow fiber membrane according to claim 2 , wherein the hollow fiber membrane has a lumen-side surface and the hollow fiber membrane comprising a membrane material comprising a hydrophobic polymer and a hydrophilic polymer, wherein an elution of the hydrophilic polymer after a storage period of 30 days at 80° C. and a relative humidity of <5%, is less than 4000*10 −7 mg/per single fiber, and in that the hollow fiber membrane on the lumen-side surface has a zeta potential of −1 mV to less than −7 mV.

14. The hollow fiber membrane according to claim 2 , wherein the hollow fiber membrane has an inner lumen surface and the hollow fiber membrane comprising a membrane material comprising a hydrophobic polymer and a hydrophilic polymer, wherein an elution of the hydrophilic polymer after a storage period of 30 days at 80° C. and a relative humidity of <5%, is less than 4000*10 −7 mg/per single fiber and the inner lumen surface has a contact angle with water, measured according to the method “Determination of the contact angle θ”, of less than 57°.

15. The hollow fiber membrane according to claim 2 , comprising a membrane material comprising a hydrophobic and a hydrophilic polymer, wherein an elution of the hydrophilic polymer after a storage period of 30 days at 80° C. and a relative humidity of <5%, is less than 4000*10 −7 mg/per single fiber the ratio of the sieving coefficients for albumin, measured after 5 min, to the sieving coefficient, measured after 30 min, according to DIN EN ISO 8637:2014, being less than 7.

16. The hollow fiber membrane according to claim 2 , comprising a membrane material comprising a hydrophobic and a hydrophilic polymer, wherein a platelet loss measured according to “Determination of Platelet Loss” method, as disclosed, is less than 50%.

17. A hollow fiber membrane filter comprising a plurality of hollow fiber membranes according to claim 2 .

18. A dialyzer for hemodialysis comprising a plurality of hollow fiber membranes according to claim 2 .

Assignees

• Fresenius Medical Care Deutschland Gmbh

Inventors

• Paul Michael
• Fislage Rainer
• Hansel Dietmar

Classifications

• B01D71/68

  Polysulfones; Polyethersulfones · CPC title

• B01D69/144

  containing embedded or bound biomolecules · CPC title

• A61M2205/7527

  liquophilic, hydrophilic · CPC title

• B01D2325/38

  Hydrophobic membranes · CPC title

• B01D69/02

  characterised by their properties · CPC title